TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2029614
log Bayes Factor = <0.0001
Chromosome 14   position 99,547,267  (GRCh37) Explore rs2029614 on Ensembl!
Variant rs2029614 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
D22.5 Melanocytic naevi of trunk
0.000 0.983 0.017
C91 Lymphoid leukaemia
0.016 0.984 0.000
C91.1 Chronic lymphocytic leukaemia
0.016 0.984 0.000
C91.0 Acute lymphoblastic leukaemia
0.015 0.985 0.000
C84.4 Peripheral T-cell lymphoma
0.015 0.985 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.014 0.986 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.014 0.986 0.000
C91.5 Adult T-cell leukaemia
0.013 0.987 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.013 0.987 0.000
Y45.0 Opioids and related analgesics
0.013 0.987 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.012 0.988 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.012 0.988 0.000
C92 Myeloid leukaemia
0.012 0.988 0.000
M25.75 Osteophyte (Pelvic region and thigh)
0.012 0.988 0.000
C83.0 Small cell (diffuse)
0.012 0.988 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.012 0.988 0.000
C91.7 Other lymphoid leukaemia
0.012 0.988 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.012 0.988 0.000
C91.3 Prolymphocytic leukaemia
0.012 0.988 0.000
C91.2 Subacute lymphocytic leukaemia
0.012 0.988 0.000
M25.7 Osteophyte
0.011 0.989 0.000
C91.9 Lymphoid leukaemia, unspecified
0.011 0.989 0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts
0.011 0.989 0.000
D68.8 Other specified coagulation defects
0.000 0.989 0.011
T82.5 Mechanical complication of other cardiac and vascular devices and implants
0.011 0.989 0.000
M25.46 Effusion of joint (Lower leg)
0.011 0.989 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.010 0.989 0.000
C94 Other leukaemias of specified cell type
0.010 0.989 0.000
C93 Monocytic leukaemia
0.010 0.989 0.000
C86 Other specified types of T/NK-cell lymphoma
0.010 0.989 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.010 0.990 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.010 0.990 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.010 0.990 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.010 0.990 0.000
C84.3 Lymphoepithelioid lymphoma
0.010 0.990 0.000
C84.2 T-zone lymphoma
0.010 0.990 0.000
C84.1 Sezary's diease
0.010 0.990 0.000
C84.0 Mycosis fungoides
0.010 0.990 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.010 0.990 0.000
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts
0.010 0.990 0.000
C84.5 Other and unspecified T-cell lymphomas
0.010 0.990 0.000
C92.1 Chronic myeloid leukaemia
0.010 0.990 0.000
C95 Leukaemia of unspecified cell type
0.010 0.990 0.000
Y42.5 Other oestrogens and progestogens
0.010 0.990 0.000
D68 Other coagulation defects
0.000 0.990 0.010
D68.2 Hereditary deficiency of other clotting factors
0.000 0.990 0.010
C92.0 Acute myeloid leukaemia
0.010 0.990 0.000
M25.77 Osteophyte (Ankle and foot)
0.010 0.990 0.000
C91.4 Hairy-cell leukaemia
0.010 0.990 0.000
M25.4 Effusion of joint
0.010 0.990 0.000
C88 Malignant immunoproliferative diseases
0.009 0.990 0.000
C83.3 Large cell (diffuse)
0.009 0.991 0.000
C81 Hodgkin's disease
0.009 0.991 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.009 0.991 0.000
M25.76 Osteophyte (Lower leg)
0.009 0.991 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.009 0.991 0.000
C85.0 Lymphosarcoma
0.009 0.991 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.009 0.991 0.000
C83.7 Burkitt's tumour
0.009 0.991 0.000
C83.6 Undifferentiated (diffuse)
0.009 0.991 0.000
C83.5 Lymphoblastic (diffuse)
0.009 0.991 0.000
C83.4 Immunoblastic (diffuse)
0.009 0.991 0.000
C83.2 Mixed small and large cell (diffuse)
0.009 0.991 0.000
M25.74 Osteophyte (Hand)
0.009 0.991 0.000
C92.9 Myeloid leukaemia, unspecified
0.009 0.991 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.009 0.991 0.000
C92.7 Other myeloid leukaemia
0.009 0.991 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.009 0.991 0.000
C92.5 Acute myelomonocytic leukaemia
0.009 0.991 0.000
C92.4 Acute promyelocytic leukaemia
0.009 0.991 0.000
C92.3 Myeloid sarcoma
0.009 0.991 0.000
C92.2 Subacute myeloid leukaemia
0.009 0.991 0.000
M25 Other joint disorders, not elsewhere classified
0.009 0.991 0.000
T82.0 Mechanical complication of heart valve prosthesis
0.009 0.991 0.000
T82.2 Mechanical complication of coronary artery bypass and valve grafts
0.009 0.991 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.009 0.991 0.000
M25.72 Osteophyte (Upper arm)
0.008 0.991 0.000
D68.6 Other Thrombophilia
0.000 0.991 0.008
M25.71 Osteophyte (Shoulder region)
0.008 0.991 0.000
C83.1 Small cleaved cell (diffuse)
0.008 0.991 0.000
D68.5 Primary Thrombophilia
0.000 0.992 0.008
M25.79 Osteophyte (Site unspecified)
0.008 0.992 0.000
M25.73 Osteophyte (Forearm)
0.008 0.992 0.000
M25.70 Osteophyte (Multiple sites)
0.008 0.992 0.000
T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis
0.008 0.992 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.008 0.992 0.000
C82.0 Small cleaved cell, follicular
0.008 0.992 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.008 0.992 0.000
D68.9 Coagulation defect, unspecified
0.000 0.992 0.008
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.008 0.992 0.000
S32.00 Fracture of lumbar vertebra (closed)
0.008 0.992 0.000
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts
0.008 0.992 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.008 0.992 0.000
T82.1 Mechanical complication of cardiac electronic device
0.008 0.992 0.000
T82.4 Mechanical complication of vascular dialysis catheter
0.008 0.992 0.000
T82.9 Unspecified complication of cardiac and vascular prosthetic device, implant and graft
0.008 0.992 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.008 0.992 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.008 0.992 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.008 0.992 0.000
C86.4 Blastic NK-cell lymphoma
0.008 0.992 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.008 0.992 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.008 0.992 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.008 0.992 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.008 0.992 0.000
C93.9 Monocytic leukaemia, unspecified
0.008 0.992 0.000
C93.7 Other monocytic leukaemia
0.008 0.992 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.008 0.992 0.000
C93.2 Subacute monocytic leukaemia
0.008 0.992 0.000
C93.1 Chronic monocytic leukaemia
0.008 0.992 0.000
C93.0 Acute monocytic leukaemia
0.008 0.992 0.000
C94.7 Other specified leukaemias
0.008 0.992 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.008 0.992 0.000
C94.5 Acute myelofibrosis
0.008 0.992 0.000
C94.4 Acute panmyelosis
0.008 0.992 0.000
C94.3 Mast cell leukaemia
0.008 0.992 0.000
C94.2 Acute megakaryoblastic leukaemia
0.008 0.992 0.000
C94.1 Chronic erythraemia
0.008 0.992 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.008 0.992 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.008 0.992 0.000
C96.8 Histiocytic sarcoma
0.008 0.992 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.008 0.992 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.008 0.992 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.008 0.992 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.008 0.992 0.000
C96.3 True histiocytic lymphoma
0.008 0.992 0.000
C96.2 Malignant mast cell tumour
0.008 0.992 0.000
C96.1 Malignant histiocytosis
0.008 0.992 0.000
C96.0 Letterer-Siwe disease
0.008 0.992 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.008 0.992 0.000
C82.6 Cutaneous follicle centre lymphoma
0.008 0.992 0.000
C82.5 Diffuse follicle centre lymphoma
0.008 0.992 0.000
C82.4 Follicular lymphoma grade IIIb
0.008 0.992 0.000
C82.3 Follicular lymphoma grade IIIa
0.008 0.992 0.000
C82.2 Large cell, follicular
0.008 0.992 0.000
D22 Melanocytic naevi
0.000 0.992 0.008
C95.7 Other leukaemia of unspecified cell type
0.007 0.992 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.007 0.992 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.007 0.992 0.000
C95.0 Acute leukaemia of unspecified cell type
0.007 0.992 0.000
M25.78 Osteophyte (Other)
0.008 0.992 0.000
D68.4 Acquired coagulation factor deficiency
0.000 0.992 0.007
D68.1 Hereditary factor XI deficiency
0.000 0.992 0.007
I60.9 Subarachnoid haemorrhage, unspecified
0.008 0.992 0.000
M25.42 Effusion of joint (Upper arm)
0.007 0.992 0.000
K63.2 Fistula of intestine
0.008 0.992 0.000
M25.6 Stiffness of joint, not elsewhere classified
0.007 0.993 0.000
M25.40 Effusion of joint (Multiple sites)
0.007 0.993 0.000
M24 Other specific joint derangements
0.007 0.993 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.007 0.993 0.000
M24.4 Recurrent dislocation and subluxation of joint
0.007 0.993 0.000
C95.9 Leukaemia, unspecified
0.007 0.993 0.000
M25.44 Effusion of joint (Hand)
0.007 0.993 0.000
K50.9 Crohn's disease, unspecified
0.007 0.993 0.000
C81.0 Lymphocytic predominance
0.007 0.993 0.000
M25.43 Effusion of joint (Forearm)
0.007 0.993 0.000
D68.0 Von Willebrand's disease
0.000 0.993 0.007
M25.45 Effusion of joint (Pelvic region and thigh)
0.007 0.993 0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.000 0.993 0.007
M25.49 Effusion of joint (Site unspecified)
0.007 0.993 0.000
M25.48 Effusion of joint (Other)
0.007 0.993 0.000
M25.41 Effusion of joint (Shoulder region)
0.007 0.993 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.007 0.993 0.000
C88.7 Other malignant immunoproliferative diseases
0.007 0.993 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.007 0.993 0.000
C88.3 Immunoproliferative small intestinal disease
0.007 0.993 0.000
C88.2 Gamma heavy chain disease
0.007 0.993 0.000
C88.1 Alpha heavy chain disease
0.007 0.993 0.000
Y45.5 4-Aminophenol derivatives
0.007 0.993 0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction
0.007 0.993 0.000
C81.7 Other Hodgkin's disease
0.007 0.993 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.007 0.993 0.000
C81.3 Lymphocytic depletion
0.007 0.993 0.000
C81.2 Mixed cellularity
0.007 0.993 0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)
0.007 0.993 0.000
M24.2 Disorder of ligament
0.007 0.993 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.007 0.993 0.000
M24.41 Recurrent dislocation and subluxation of joint (Shoulder region)
0.007 0.993 0.000
M25.9 Joint disorder, unspecified
0.007 0.993 0.000
D22.1 Melanocytic naevi of eyelid, including canthus
0.000 0.993 0.007
Y51 Drugs primarily affecting the autonomic nervous system
0.007 0.993 0.000
M25.68 Stiffness of joint, not elsewhere classified (Other)
0.007 0.993 0.000
I60 Subarachnoid haemorrhage
0.007 0.993 0.000
M25.2 Flail joint
0.006 0.993 0.000
M25.1 Fistula of joint
0.006 0.993 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.007 0.993 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.006 0.993 0.000
I69 Sequelae of cerebrovascular disease
0.007 0.993 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.006 0.994 0.000
Y45.4 Antirheumatics
0.006 0.994 0.000
C81.1 Nodular sclerosis
0.006 0.994 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.006 0.994 0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases
0.006 0.994 0.000
M24.24 Disorder of ligament (Hand)
0.006 0.994 0.000
D22.6 Melanocytic naevi of upper limb, including shoulder
0.000 0.994 0.006
Y59 Other and unspecified vaccines and biological substances
0.006 0.994 0.000
M25.8 Other specified joint disorders
0.006 0.994 0.000
M24.8 Other specific joint derangements, not elsewhere classified
0.006 0.994 0.000
S06.5 Traumatic subdural haemorrhage
0.006 0.994 0.000
X60-X84 Intentional self-harm
0.006 0.994 0.000
D22.0 Melanocytic naevi of lip
0.000 0.994 0.006
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.006 0.994 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.006 0.994 0.000
M25.0 Haemarthrosis
0.006 0.994 0.000
M25.64 Stiffness of joint, not elsewhere classified (Hand)
0.006 0.994 0.000
V23.4 Driver injured in traffic accident
0.006 0.994 0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)
0.006 0.994 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.006 0.994 0.000
W50-W64 Exposure to animate mechanical forces
0.006 0.994 0.000
D22.7 Melanocytic naevi of lower limb, including hip
0.000 0.994 0.006
D22.4 Melanocytic naevi of scalp and neck
0.000 0.994 0.006
Y58 Bacterial vaccines
0.006 0.994 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.006 0.994 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.006 0.994 0.000
Chapter XX External causes of morbidity and mortality
0.006 0.994 0.000
M24.7 Protrusio acetabuli
0.006 0.994 0.000
Y42.9 Other and unspecified hormone antagonists
0.006 0.994 0.000
Y42.4 Oral contraceptives
0.006 0.994 0.000
Y42.2 Antithyroid drugs
0.006 0.994 0.000
Y42.1 Thyroid hormones and substitutes
0.006 0.994 0.000
V20-V29 Motorcycle rider injured in transport accident
0.006 0.994 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.006 0.994 0.000
M24.3 Pathological dislocation and subluxation of joint, not elsewhere classified
0.006 0.994 0.000
M24.0 Loose body in joint
0.006 0.994 0.000
C90.3 Solitary plasmacytoma
0.006 0.994 0.000
C90.1 Plasma cell leukaemia
0.006 0.994 0.000
W50.9 Unspecified place
0.006 0.994 0.000
Y44 Agents primarily affecting blood constituents
0.006 0.994 0.000
V23 Motorcycle rider injured in collision with car, pick-up truck or van
0.006 0.994 0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation
0.006 0.994 0.000
S32.0 Fracture of lumbar vertebra
0.006 0.994 0.000
M24.47 Recurrent dislocation and subluxation of joint (Ankle and foot)
0.006 0.994 0.000
C81.9 Hodgkin's disease, unspecified
0.006 0.994 0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person
0.006 0.994 0.000
M24.45 Recurrent dislocation and subluxation of joint (Pelvic region and thigh)
0.006 0.994 0.000
M24.44 Recurrent dislocation and subluxation of joint (Hand)
0.006 0.994 0.000
M20-M25 Other joint disorders
0.006 0.994 0.000
Y40 Systemic antibiotics
0.006 0.994 0.000
V40-V49 Car occupant injured in transport accident
0.006 0.994 0.000
M21 Other acquired deformities of limbs
0.006 0.994 0.000
V49 Car occupant injured in other and unspecified transport accidents
0.006 0.994 0.000
Y48 Anaesthetics and therapeutic gases
0.006 0.994 0.000
S06 Intracranial injury
0.006 0.994 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.006 0.994 0.000
M22 Disorders of patella
0.006 0.994 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.006 0.994 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.006 0.994 0.000
C90.2 Plasmacytoma, extramedullary
0.006 0.994 0.000
Y41.5 Antiviral drugs
0.006 0.994 0.000
M25.47 Effusion of joint (Ankle and foot)
0.006 0.994 0.000
M24.6 Ankylosis of joint
0.006 0.994 0.000
M25.69 Stiffness of joint, not elsewhere classified (Site unspecified)
0.005 0.994 0.000
M25.65 Stiffness of joint, not elsewhere classified (Pelvic region and thigh)
0.005 0.994 0.000
M25.63 Stiffness of joint, not elsewhere classified (Forearm)
0.005 0.994 0.000
M25.62 Stiffness of joint, not elsewhere classified (Upper arm)
0.005 0.994 0.000
M25.60 Stiffness of joint, not elsewhere classified (Multiple sites)
0.005 0.994 0.000
Y54.3 Benzothiadiazine derivatives
0.006 0.994 0.000
M25.97 Joint disorder, unspecified (Ankle and foot)
0.006 0.994 0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)
0.006 0.994 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.006 0.994 0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified
0.006 0.994 0.000
S06.6 Traumatic subarachnoid haemorrhage
0.006 0.994 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.005 0.994 0.000
M24.27 Disorder of ligament (Ankle and foot)
0.006 0.994 0.000
M25.83 Other specified joint disorders (Forearm)
0.006 0.994 0.000
M21.4 Flat foot [pes planus] (acquired)
0.006 0.994 0.000
M24.23 Disorder of ligament (Forearm)
0.005 0.994 0.000
D22.9 Melanocytic naevi, unspecified
0.000 0.994 0.005
M24.9 Joint derangement, unspecified
0.005 0.994 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.005 0.994 0.000
Y41.4 Anthelminthics
0.005 0.994 0.000
Y41.3 Other antiprotozoal drugs
0.005 0.994 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.005 0.994 0.000
Y41.1 Antimycobacterial drugs
0.005 0.994 0.000
Y41.0 Sulphonamides
0.005 0.994 0.000
M24.49 Recurrent dislocation and subluxation of joint (Site unspecified)
0.005 0.994 0.000
M24.48 Recurrent dislocation and subluxation of joint (Other)
0.005 0.994 0.000
M24.46 Recurrent dislocation and subluxation of joint (Lower leg)
0.005 0.994 0.000
M24.43 Recurrent dislocation and subluxation of joint (Forearm)
0.005 0.994 0.000
M24.42 Recurrent dislocation and subluxation of joint (Upper arm)
0.005 0.994 0.000
M24.40 Recurrent dislocation and subluxation of joint (Multiple sites)
0.005 0.994 0.000
M25.95 Joint disorder, unspecified (Pelvic region and thigh)
0.005 0.994 0.000
M21.47 Flat foot [pes planus] (acquired)-Ankle/foot
0.005 0.994 0.000
S06.2 Diffuse brain injury
0.005 0.994 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.005 0.994 0.000
M24.87 Other specific joint derangements, not elsewhere classified (Ankle and foot)
0.005 0.994 0.000
I69.1 Sequelae of intracerebral haemorrhage
0.005 0.994 0.000
S06.20 Diffuse brain injury (without open intracranial wound)
0.005 0.995 0.000
Y53.4 Other laxatives
0.005 0.995 0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods
0.005 0.995 0.000
Y45.8 Other analgesics and antipyretics
0.005 0.995 0.000
Y45.2 Propionic acid derivatives
0.005 0.995 0.000
T82.3 Mechanical complication of other vascular grafts
0.005 0.995 0.000
M22.4 Chondromalacia patellae
0.005 0.995 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.005 0.995 0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system
0.005 0.995 0.000
M22.2 Patellofemoral disorders
0.005 0.995 0.000
Y57 Other and unspecified drugs and medicaments
0.005 0.995 0.000
M24.5 Contracture of joint
0.005 0.995 0.000
M24.02 Loose body in joint (Upper arm)
0.005 0.995 0.000
M24.81 Other specific joint derangements, not elsewhere classified (Shoulder region)
0.005 0.995 0.000
S06.4 Epidural haemorrhage
0.005 0.995 0.000
M24.29 Disorder of ligament (Site unspecified)
0.005 0.995 0.000
M24.28 Disorder of ligament (Other)
0.005 0.995 0.000
M24.25 Disorder of ligament (Pelvic region and thigh)
0.005 0.995 0.000
M24.22 Disorder of ligament (Upper arm)
0.005 0.995 0.000
M24.20 Disorder of ligament (Multiple sites)
0.005 0.995 0.000
M30 Polyarteritis nodosa and related conditions
0.005 0.995 0.000
X78 Intentional self-harm by sharp object
0.005 0.995 0.000
M24.21 Disorder of ligament (Shoulder region)
0.005 0.995 0.000
M25.99 Joint disorder, unspecified (Site unspecified)
0.005 0.995 0.000
M25.98 Joint disorder, unspecified (Other)
0.005 0.995 0.000
M25.94 Joint disorder, unspecified (Hand)
0.005 0.995 0.000
M25.93 Joint disorder, unspecified (Forearm)
0.005 0.995 0.000
M25.92 Joint disorder, unspecified (Upper arm)
0.005 0.995 0.000
M25.91 Joint disorder, unspecified (Shoulder region)
0.005 0.995 0.000
M25.90 Joint disorder, unspecified (Multiple sites)
0.005 0.995 0.000
I60-I69 Cerebrovascular diseases
0.005 0.995 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.000 0.995 0.005
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident
0.005 0.995 0.000
Y47.1 Benzodiazepines
0.005 0.995 0.000
M24.26 Disorder of ligament (Lower leg)
0.005 0.995 0.000
D22.2 Melanocytic naevi of ear and external auricular canal
0.000 0.995 0.005
M24.75 Protrusio acetabuli-Pelvic/thigh
0.005 0.995 0.000
M25.84 Other specified joint disorders (Hand)
0.005 0.995 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.005 0.995 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.005 0.995 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.005 0.995 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.005 0.995 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.005 0.995 0.000
Y51.0 Anticholinesterase agents
0.005 0.995 0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery
0.005 0.995 0.000
M25.86 Other specified joint disorders (Lower leg)
0.005 0.995 0.000
M24.37 Pathological dislocation and subluxation of joint, not elsewhere classified (Ankle and foot)
0.005 0.995 0.000
M25.3 Other instability of joint
0.005 0.995 0.000
Y42.7 Androgens and anabolic congeners
0.005 0.995 0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours
0.005 0.995 0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics
0.005 0.995 0.000
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident
0.005 0.995 0.000
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)
0.005 0.995 0.000
V27 Motorcycle rider injured in collision with fixed or stationary object
0.005 0.995 0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.005 0.995 0.000
Y43 Primarily systemic agents
0.005 0.995 0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries
0.005 0.995 0.000
I60.5 Subarachnoid haemorrhage from vertebral artery
0.005 0.995 0.000
M25.19 Fistula of joint (Site unspecified)
0.005 0.995 0.000
M25.18 Fistula of joint (Other)
0.005 0.995 0.000
M25.17 Fistula of joint (Ankle and foot)
0.005 0.995 0.000
M25.16 Fistula of joint (Lower leg)
0.005 0.995 0.000
M25.15 Fistula of joint (Pelvic region and thigh)
0.005 0.995 0.000
M25.14 Fistula of joint (Hand)
0.005 0.995 0.000
M25.13 Fistula of joint (Forearm)
0.005 0.995 0.000
M25.12 Fistula of joint (Upper arm)
0.005 0.995 0.000
M25.11 Fistula of joint (Shoulder region)
0.005 0.995 0.000
M25.10 Fistula of joint (Multiple sites)
0.005 0.995 0.000
M25.29 Flail joint (Site unspecified)
0.005 0.995 0.000
M25.28 Flail joint (Other)
0.005 0.995 0.000
M25.27 Flail joint (Ankle and foot)
0.005 0.995 0.000
M25.26 Flail joint (Lower leg)
0.005 0.995 0.000
M25.25 Flail joint (Pelvic region and thigh)
0.005 0.995 0.000
M25.24 Flail joint (Hand)
0.005 0.995 0.000
M25.23 Flail joint (Forearm)
0.005 0.995 0.000
M25.22 Flail joint (Upper arm)
0.005 0.995 0.000
M25.21 Flail joint (Shoulder region)
0.005 0.995 0.000
M25.20 Flail joint (Multiple sites)
0.005 0.995 0.000
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified
0.000 0.995 0.005
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot
0.005 0.995 0.000
Y59.3 Immunoglobulin
0.005 0.995 0.000
I62 Other nontraumatic intracranial haemorrhage
0.005 0.995 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.005 0.995 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.005 0.995 0.000
Y53.7 Emetics
0.005 0.995 0.000
Y53.6 Antidiarrhoeal drugs
0.005 0.995 0.000
Y53.5 Digestants
0.005 0.995 0.000
Y53.3 Saline and osmotic laxatives
0.005 0.995 0.000
Y53.2 Stimulant laxatives
0.005 0.995 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.005 0.995 0.000
Y53.0 Histamine H2-receptor antagonists
0.005 0.995 0.000
Y54.9 Mineral salts, not elsewhere classified
0.005 0.995 0.000
Y54.8 Agents affecting uric acid metabolism
0.005 0.995 0.000
Y54.7 Agents affecting calcification
0.005 0.995 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.005 0.995 0.000
Y54.4 Loop [high-ceiling] diuretics
0.005 0.995 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.005 0.995 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.005 0.995 0.000
Y54.0 Mineralocorticoids
0.005 0.995 0.000
W60 Contact with plant thorns and spines and sharp leaves
0.005 0.995 0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
0.005 0.995 0.000
Y40.9 Systemic antibiotic, unspecified
0.005 0.995 0.000
I60.4 Subarachnoid haemorrhage from basilar artery
0.005 0.995 0.000
M21.8 Other specified acquired deformities of limbs
0.005 0.995 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.005 0.995 0.000
S06.40 Epidural haemorrhage (without open intracranial wound)
0.005 0.995 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.005 0.995 0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage
0.005 0.995 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.005 0.995 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.005 0.995 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.005 0.995 0.000
Y47.4 Bromine compounds
0.005 0.995 0.000
Y47.3 Paraldehyde
0.005 0.995 0.000
Y47.2 Chloral derivatives
0.005 0.995 0.000
Y47.0 Barbiturates, not elsewhere classified
0.005 0.995 0.000
V49.9 Car occupant [any] injured in unspecified traffic accident
0.005 0.995 0.000
W57.0 Home
0.005 0.995 0.000
I61 Intracerebral haemorrhage
0.005 0.995 0.000
X68 Intentional self-poisoning by and exposure to pesticides
0.005 0.995 0.000
M25.67 Stiffness of joint, not elsewhere classified (Ankle and foot)
0.005 0.995 0.000
M21.7 Unequal limb length (acquired)
0.005 0.995 0.000
M24.84 Other specific joint derangements, not elsewhere classified (Hand)
0.005 0.995 0.000
S06.8 Other intracranial injuries
0.005 0.995 0.000
X00-X09 Exposure to smoke, fire and flames
0.005 0.995 0.000
V01-V09 Pedestrian injured in transport accident
0.005 0.995 0.000
Y59.9 Vaccine or biological substance, unspecified
0.005 0.995 0.000
Y59.8 Other specified vaccines and biological substances
0.005 0.995 0.000
Y59.2 Protozoal vaccines
0.005 0.995 0.000
Y59.1 Rickettsial vaccines
0.005 0.995 0.000
Y59.0 Viral vaccines
0.005 0.995 0.000
M25.89 Other specified joint disorders (Site unspecified)
0.005 0.995 0.000
M25.88 Other specified joint disorders (Other)
0.005 0.995 0.000
M25.82 Other specified joint disorders (Upper arm)
0.005 0.995 0.000
M25.80 Other specified joint disorders (Multiple sites)
0.005 0.995 0.000
M24.89 Other specific joint derangements, not elsewhere classified (Site unspecified)
0.005 0.995 0.000
M24.88 Other specific joint derangements, not elsewhere classified (Other)
0.005 0.995 0.000
M24.83 Other specific joint derangements, not elsewhere classified (Forearm)
0.005 0.995 0.000
M24.82 Other specific joint derangements, not elsewhere classified (Upper arm)
0.005 0.995 0.000
M24.80 Other specific joint derangements, not elsewhere classified (Multiple sites)
0.005 0.995 0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)
0.005 0.995 0.000
X63.0 Home
0.005 0.995 0.000
X84 Intentional self-harm by unspecified means
0.005 0.995 0.000
X83 Intentional self-harm by other specified means
0.005 0.995 0.000
X82 Intentional self-harm by crashing of motor vehicle
0.005 0.995 0.000
X81 Intentional self-harm by jumping or lying before moving object
0.005 0.995 0.000
X80 Intentional self-harm by jumping from a high place
0.005 0.995 0.000
X79 Intentional self-harm by blunt object
0.005 0.995 0.000
X77 Intentional self-harm by steam, hot vapours and hot objects
0.005 0.995 0.000
X76 Intentional self-harm by smoke, fire and flames
0.005 0.995 0.000
X75 Intentional self-harm by explosive material
0.005 0.995 0.000
X74 Intentional self-harm by other and unspecified firearm discharge
0.005 0.995 0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge
0.005 0.995 0.000
X72 Intentional self-harm by handgun discharge
0.005 0.995 0.000
X71 Intentional self-harm by drowning and submersion
0.005 0.995 0.000
X70 Intentional self-harm by hanging, strangulation and suffocation
0.005 0.995 0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours
0.005 0.995 0.000
X65 Intentional self-poisoning by and exposure to alcohol
0.005 0.995 0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
0.005 0.995 0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.005 0.995 0.000
X10-X19 Contact with heat and hot substances
0.005 0.995 0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery
0.005 0.995 0.000
Y54.5 Other diuretics
0.005 0.995 0.000
V43 Car occupant injured in collision with car, pick-up truck or van
0.005 0.995 0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery
0.005 0.995 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.005 0.995 0.000
S06.3 Focal brain injury
0.005 0.995 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.004 0.995 0.000
M25.09 Haemarthrosis (Site unspecified)
0.004 0.995 0.000
M25.08 Haemarthrosis (Other)
0.004 0.995 0.000
M25.07 Haemarthrosis (Ankle and foot)
0.004 0.995 0.000
M25.05 Haemarthrosis (Pelvic region and thigh)
0.004 0.995 0.000
M25.04 Haemarthrosis (Hand)
0.004 0.995 0.000
M25.03 Haemarthrosis (Forearm)
0.004 0.995 0.000
M25.02 Haemarthrosis (Upper arm)
0.004 0.995 0.000
M25.01 Haemarthrosis (Shoulder region)
0.004 0.995 0.000
M25.00 Haemarthrosis (Multiple sites)
0.004 0.995 0.000
M24.86 Other specific joint derangements, not elsewhere classified (Lower leg)
0.005 0.995 0.000
W51 Striking against or bumped into by another person
0.005 0.995 0.000
M21.1 Varus deformity, not elsewhere classified
0.005 0.995 0.000
W64 Exposure to other and unspecified animate mechanical forces
0.004 0.995 0.000
W59 Bitten or crushed by other reptiles
0.004 0.995 0.000
W58 Bitten or struck by crocodile or alligator
0.004 0.995 0.000
W56 Contact with marine animal
0.004 0.995 0.000
W54 Bitten or struck by dog
0.004 0.995 0.000
W53 Bitten by rat
0.004 0.995 0.000
W52 Crushed, pushed and stepped on by crowd or human stampede
0.004 0.995 0.000
M24.79 Protrusio acetabuli-Site unspec
0.004 0.995 0.000
M24.78 Protrusio acetabuli-Other
0.004 0.995 0.000
M24.77 Protrusio acetabuli-Ankle/foot
0.004 0.995 0.000
M24.76 Protrusio acetabuli-Lower leg
0.004 0.995 0.000
M24.74 Protrusio acetabuli-Hand
0.004 0.995 0.000
M24.73 Protrusio acetabuli-Forearm
0.004 0.995 0.000
M24.72 Protrusio acetabuli-Upper arm
0.004 0.995 0.000
M24.71 Protrusio acetabuli-Shldr region
0.004 0.995 0.000
M24.70 Protrusio acetabuli-Mult sites
0.004 0.995 0.000
Y50.9 Central nervous system stimulant, unspecified
0.004 0.995 0.000
Y50.8 Other central nervous system stimulants
0.004 0.995 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.004 0.995 0.000
Y50.1 Opioid receptor antagonists
0.004 0.995 0.000
Y50.0 Analeptics
0.004 0.995 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.004 0.995 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.004 0.995 0.000
Y55.5 Anticommon cold drugs
0.004 0.995 0.000
Y55.4 Expectorants
0.004 0.995 0.000
Y55.3 Antitussives
0.004 0.995 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.004 0.995 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.004 0.995 0.000
Y55.0 Oxytocic drugs
0.004 0.995 0.000
Y58.9 Other and unspecified bacterial vaccines
0.004 0.995 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.004 0.995 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.004 0.995 0.000
Y58.5 Diphtheria vaccine
0.004 0.995 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.